Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Ghazala Hayat"'
Autor:
Benjamin Kiaei, Maaria Chaudhry, Sumona Banerjee, Jonathan Brewer, Yongzhen Chen, Farid Khasiyev, Miguel A. Guzman, Ghazala Hayat
Publikováno v:
BMC Neurology, Vol 24, Iss 1, Pp 1-5 (2024)
Abstract Background Immune checkpoint inhibitors are a relatively new advancement in the world of cancer therapy. As such, their adverse effects have yet to be fully understood, with only recent literature documenting autoimmune phenomena secondary t
Externí odkaz:
https://doaj.org/article/792abcd9906e421982ed8e68e52a85d7
Publikováno v:
Clinical and Translational Neuroscience, Vol 4 (2020)
Amyotrophic lateral sclerosis is a neurodegenerative illness that causes gradual loss of muscle function. Patients eventually develop bulbar impairment, requiring extensive respiratory support. Noninvasive ventilation (NIV) has gained attention as an
Externí odkaz:
https://doaj.org/article/00f6da24c98a45d2a3b485850f71e417
Publikováno v:
Frontiers in Neurology, Vol 7 (2016)
Background: Creutzfeldt-Jakob disease (CJD) is a rare, rapidly progressive neurodegenerative disease that almost always results in death in under a year from onset of symptoms. Here, we report four cases of CJD with different clinical presentations d
Externí odkaz:
https://doaj.org/article/457cb952f5024fddabd4e5ed3e226426
Autor:
Syeda Beenish Bareeqa, Syeda Sana Samar, Sufiyan Kamal, Yasir Masood, null Allahyar, Syed Ijlal Ahmed, Ghazala Hayat
Publikováno v:
Neurodegenerative disease management. 12(3)
Parkinson's disease (PD) is a nervous system disease that predominantly affects neurons of the brain that controls voluntary movement and behavioral processes such as mood, reward, addiction and stress. There is a wide spectrum of problems that can p
Autor:
Gary L. Pattee, Ashley Whyte-Rayson, Andrew A. Wolff, Jeremy M. Shefner, Lisa Meng, Jesus S. Mora, Lorne Zinman, Steve Vucic, Terry Heiman-Patterson, Stephen J. Kolb, James Caress, Bettina M. Cockroft, Carlayne E. Jackson, Timothy M. Miller, Michael D. Weiss, Ghazala Hayat, Shumaila Sultan, Benjamin Rix Brooks, Daragh Heitzman, Tuan Vu, Merrilee Needham, Dianna Quan, Genevieve Matte, Shafeeq Ladha, Orla Hardiman, Fady I. Malik, Zachary Simmons, Wendy Johnston, Christen Shoesmith, Namita Goyal, Erik P. Pioro, James Wymer, David Schultz, Leonard H. van den Berg, Cynthia Bodkin, Lawrence Korngut, Jeffrey Statland, Michael Pulley, Bjorn Oskarsson, Chafic Karam, Angela Genge, Matthew C. Kiernan, Jenny Wei, Annie Dionne, Jinsy A. Andrews, Noah Lechtzin, Stephen A. Goutman, Andrea Swenson, Dominic B. Fee, Kerri Schellenberg, Robert D. Henderson, Kourosh Rezania, Stacy A. Rudnicki
Publikováno v:
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. 22:287-299
To evaluate safety, dose response, and preliminary efficacy of reldesemtiv over 12 weeks in patients with amyotrophic lateral sclerosis (ALS). Methods: Patients (≤2 years since diagnosis) with slow...
Autor:
Hiroshi, Mitsumoto, Grace, Jang, Ikjae, Lee, Zachary, Simmons, Alexander V, Sherman, Daragh, Heitzman, Eric, Sorenson, Ken, Cheung, Jinsy, Andrews, Matthew, Harms, Neil A, Shneider, Regina, Santella, Sabrina, Paganoni, Senda, Ajroud-Driss, J Americo M, Fernandes, Katherine M, Burke, Kelly, Gwathmey, Ali A, Habib, Nicholas J, Maragakis, David, Walk, Christina, Fournier, Terry, Heiman-Patterson, James, Wymer, Frank, Diaz, Stephen N, Scelsa, Lauren, Elman, Angela, Genge, Stephen A, Goutman, Ghazala, Hayat, Omar, Jawdat, Wendy S, Johnston, Nanette C, Joyce, Edward J, Kasarskis, Yaz Y, Kisanuki, Catherine, Lomen-Hoerth, Michael T, Pulley, Jaimin S, Shah, Christen, Shoesmith, Lorne, Zinman
Introduction/Aims. Primary lateral sclerosis (PLS) is exceedingly rare and has been an enigmatic disease. Recent progress has drastically changed this perception, with early biomarkers being investigated and potential medications for PLS emerging at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::199e0ab7e9df901d229ea3fce3df5843
Autor:
Ghazala Hayat, Glenn Lopate, Asma Malik, Jacqueline Jones, Alan Pestronk, Bassam Malo, Rama Atluri
Publikováno v:
Journal of Clinical Neuromuscular Disease. 20:103-110
Objective To assess the intraepidermal nerve fiber density in patients diagnosed with fibromyalgia (FM) and to evaluate the role of IgM binding to trisulfated heparin disaccharide (TS-HDS) in these patients. Methods FM is a poorly understood pain dis
Autor:
Regina M. Santella, Chafic Karam, Sharon P. Nations, Ghazala Hayat, Yunxia Wang, Laura Herbelin, Maureen Walsh, Heather M. Wilkins, Hiroshi Mitsumoto, Jeffrey Statland, Richard J. Barohn, Tahseen Mozaffar, Jonathan S. Katz, J. Americo Fernandes, Lauren Elman, David Saperstein, Russell H. Swerdlow, Dan H. Moore, Abdulbaki Agbas, Mazen M. Dimachkie
Publikováno v:
Muscle & Nerve. 59:201-207
Introduction Rasagiline is a monoamine oxidase B (MAO-B) inhibitor with possible neuroprotective effects in patients with amyotrophic lateral sclerosis (ALS). Methods We performed a randomized, double-blind, placebo-controlled trial of 80 ALS partici
Autor:
Jeremy M, Shefner, Jinsy A, Andrews, Angela, Genge, Carlayne, Jackson, Noah, Lechtzin, Timothy M, Miller, Bettina M, Cockroft, Lisa, Meng, Jenny, Wei, Andrew A, Wolff, Fady I, Malik, Cynthia, Bodkin, Benjamin R, Brooks, James, Caress, Annie, Dionne, Dominic, Fee, Stephen A, Goutman, Namita A, Goyal, Orla, Hardiman, Ghazala, Hayat, Terry, Heiman-Patterson, Daragh, Heitzman, Robert D, Henderson, Wendy, Johnston, Chafic, Karam, Matthew C, Kiernan, Stephen J, Kolb, Lawrence, Korngut, Shafeeq, Ladha, Genevieve, Matte, Jesus S, Mora, Merrilee, Needham, Bjorn, Oskarsson, Gary L, Pattee, Erik P, Pioro, Michael, Pulley, Dianna, Quan, Kourosh, Rezania, Kerri L, Schellenberg, David, Schultz, Christen, Shoesmith, Zachary, Simmons, Jeffrey, Statland, Shumaila, Sultan, Andrea, Swenson, Leonard H Van Den, Berg, Tuan, Vu, Steve, Vucic, Michael, Weiss, Ashley, Whyte-Rayson, James, Wymer, Lorne, Zinman, Stacy A, Rudnicki
Publikováno v:
Amyotrophic lateral sclerosis & frontotemporal degeneration
Objective: To evaluate safety, dose response, and preliminary efficacy of reldesemtiv over 12 weeks in patients with amyotrophic lateral sclerosis (ALS). Methods: Patients (≤2 years since diagnosis) with slow upright vital capacity (SVC) of ≥60%
Autor:
James Wymer, Tuan Vu, Yuebing Li, Pariwat Thaisetthawatkul, M Jacoby, Andrea Swenson, Aiesha Ahmed, Jau Shin Lou, Mamatha Pasnoor, Ted M. Burns, C Parks, Michael K. Hehir, David Walk, Stephen N. Scelsa, Shafeeq Ladha, Ghazala Hayat, Gordon Smith, Jaya Trivedi, Byron J. Gajewski, William Mallonee, Richard J. Barohn, P Shlemon, Omar Jawdat, Robert M. Pascuzzi, Matthew Wicklund, Tiyonnoh M. Cash, Noah Kolb, Sindhu Ramchandren, Jeffrey W. Ralph, L Brown, Paul Twydell, Hani Kushlaf, Gil I. Wolfe, Mazen M. Dimachkie, S Austin, Michael Pulley, Y Hussainn, David Saperstein, Stanley Iyadurai, Dianna Quan, T Liu, Chafic Karam, Amro M. Stino, D Heitzman, Anza B. Memon, Thomas H. Brannagan, A Tobon, Khema Sharma, M Ahmed, Kim S. Kimminau, Vera Bril, John T. Kissel, Christen Kutz, N Verma, M Bazant, Richard A. Lewis, Suur Biliciler, Alexandru Barboi, K Salajegheh, Laura Herbelin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a7b5b3e05fb6f7b8b2a916d258850ca1
https://doi.org/10.25302/05.2020.cer.130602496
https://doi.org/10.25302/05.2020.cer.130602496